← Leaderboards
Ulf Dettmer
Brigham And Women'S Hospital
$4,942,215
Attributed
$7,446,535
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2017–25$2.5M$1.9M$1.3M$625K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,446,535 · 5
By mechanism
RF1$4,314,569 · 2
R01$2,627,341 · 2
R21$504,625 · 1
Top collaborators
- Nagendran Ramalingam3 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Jie Shen$46,115,873
- Mel B Feany$26,965,920
- Vikram Khurana$7,485,027
- Nagendran Ramalingam$2,996,571
- Gary P. H. Ho$1,466,040
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposBrain DiseasesNeuronsS DiseaseMissense MutationCellsProteinsPhysiologicalInsightSynucleinopathyMultiple System AtrophyParkinson DiseaseAlpha SynucleinPathologicCell Culture TechniquesPhosphorylationLewy BodiesPathogenesisPreventHomeostasisNeuritesMouse ModelLeadNeurodegenerative Disorders
Grant awards (9)
Polo-like-kinase-2-dependent α-Synuclein Serine-129 Phosphorylation: a Physiological RoleDuring Synaptic Activity$694,072
R01 · FY2025 · NS · contact PI
How Serine-129 Phosphorylation Status Affects the Spreading of α-Synuclein Pathology in Vivo: a Study in Knock-in Animals$2,192,716
RF1 · FY2023 · NS · contact PI
Polo-like-kinase-2-dependent α-Synuclein Serine-129 Phosphorylation: a Physiological RoleDuring Synaptic Activity$2,121,853
RF1 · FY2022 · NS · contact PI
Contrasting pathomechanisms of membrane versus cytosol alpha-synuclein excess$504,625
R21 · FY2021 · NS · contact PI
Stabilizing native α-synuclein homeostasis to prevent insoluble α-synuclein aggregates$386,653
R01 · FY2021 · NS · contact PI
Stabilizing native α-synuclein homeostasis to prevent insoluble α-synuclein aggregates$386,654
R01 · FY2020 · NS · contact PI
Stabilizing native α-synuclein homeostasis to prevent insoluble α-synuclein aggregates$386,654
R01 · FY2019 · NS · contact PI
Stabilizing native α-synuclein homeostasis to prevent insoluble α-synuclein aggregates$386,654
R01 · FY2018 · NS · contact PI
Stabilizing native α-synuclein homeostasis to prevent insoluble α-synuclein aggregates$386,654
R01 · FY2017 · NS · contact PI